Pharma Lobbying Hit Record Amid Drug Pricing Debate (Correct)

The main influence firm for drugmakers spent a record amount lobbying last year, as Democrats attempted to pass legislation to allow the government to negotiate for better prices on medicines.

The Pharmaceutical Research and Manufacturers of America spent nearly $29.6 million on lobbying in 2021, the most the group has ever spent, according to federal disclosures filed Thursday. PhRMA wasn’t alone: the Biotechnology Innovation Organization, which represents biotechnology companies, spent nearly $13.3 million in 2021, also a record for the group.

The most PhRMA had previously spent on lobbying was $28.9 million in 2019, according to federal disclosures. BIO spent ...